Bruno Marques has been building and leading the Process & Product Development team at Century Therapeutics toward manufacturing and supply of adult stem cell-derived allogeneic therapies against cancer. Prior to Century, he spent 14 years developing and commercializing biopharmaceutical products at Merck and GlaxoSmithKline.

‍

At GSK, Bruno held leadership roles in process development and portfolio management, contributing to the launch of several biological products. He eventually joined GSK’s Cell & Gene Therapy platform as Director of Manufacturing Strategy in support of autologous immunotherapies. Bruno is a Chemical Engineer by training, with a PhD from Carnegie Mellon University and a BS from the Illinois Institute of Technology.